This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jan 10;34(2):105-6.

doi: 10.1200/JCO.2015.64.3395. Epub 2015 Nov 16.

Metastatic Rhabdomyosarcoma: Still Room for Improvement

Leonard H Wexler¹

Affiliations

PMID: 26573072
DOI: 10.1200/JCO.2015.64.3395

Editorial

Metastatic Rhabdomyosarcoma: Still Room for Improvement

Leonard H Wexler. J Clin Oncol. 2016.

. 2016 Jan 10;34(2):105-6.

doi: 10.1200/JCO.2015.64.3395. Epub 2015 Nov 16.

Author

Leonard H Wexler¹

Affiliation

¹ Memorial Sloan Kettering Cancer Center, New York, NY wexlerl@mskcc.org.

PMID: 26573072
DOI: 10.1200/JCO.2015.64.3395

No abstract available

PubMed Disclaimer

Comment on

Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Weigel BJ, Lyden E, Anderson JR, Meyer WH, Parham DM, Rodeberg DA, Michalski JM, Hawkins DS, Arndt CA. Weigel BJ, et al. J Clin Oncol. 2016 Jan 10;34(2):117-22. doi: 10.1200/JCO.2015.63.4048. Epub 2015 Oct 26. J Clin Oncol. 2016. PMID: 26503200 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations